NEWS
Accuray in the Media
The most recent news articles and media coverage of Accuray, our treatment delivery systems and software, and our partners around the world.
-
Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
SUNNYVALE, Calif. , Feb. 5, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy ® System in the treatment of advanced rectal cancer. Radiotherapy, with or without chemotherapy, followed by surgery […]
-
Accuray Reports Fiscal 2020 Second Quarter Financial Results
SUNNYVALE, Calif. , Jan. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019 . Recent Company Highlights Gross orders of $98.6 million , including 11 orders from China Net orders of $89.9 […]
-
Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020
SUNNYVALE, Calif. , Jan. 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m. […]
-
Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
Company to present on Wednesday, January 15, 2020 at 10 am PT / 1 pm ET SUNNYVALE, Calif. , Jan. 13, 2020 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) will be discussing its business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare […]
-
Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
SUNNYVALE, Calif. , Jan. 8, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife ® System provided excellent disease control with […]
